Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Decreases By 53.5%

Biomerica, Inc. (NASDAQ:BMRA) was the target of a large decline in short interest during the month of December. As of December 31st, there was short interest totalling 364,100 shares, a decline of 53.5% from the December 15th total of 782,800 shares. Based on an average trading volume of 894,000 shares, the days-to-cover ratio is presently 0.4 days.

Biomerica Price Performance

Biomerica stock traded up $0.02 during mid-day trading on Wednesday, hitting $0.35. 368,232 shares of the company’s stock traded hands, compared to its average volume of 271,322. The firm has a 50 day simple moving average of $0.33 and a two-hundred day simple moving average of $0.34. Biomerica has a fifty-two week low of $0.24 and a fifty-two week high of $1.35. The stock has a market cap of $5.89 million, a price-to-earnings ratio of -0.95 and a beta of -1.04.

Biomerica (NASDAQ:BMRA) last posted its earnings results on Tuesday, January 14th. The company reported ($0.06) earnings per share (EPS) for the quarter. Biomerica had a negative return on equity of 84.62% and a negative net margin of 111.89%.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.